LP172575-5
rifAXIMin
Active
Description
Rifaximin is a semisynthetic antibiotic based on rifamycin. It has poor oral bioavailability, meaning that very little of the drug will be absorbed into the blood stream when it is taken orally. Rifaximin is used in the treatment of traveler's diarrhea and hepatic encephalopathy, for which it received orphan drug status from the U.S. Food and Drug Administration in 1998. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia
Basic Part Properties
- Part Display Name
- rifAXIMin
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2013-01-30
- Construct for LOINC Short Name
- rifAXIMin
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP172575-5 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP172575-5
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 利福昔明 Synonyms: 利福西亚胺; |
| es-ES | Spanish (Spain) | Rifaximin |
| it-IT | Italian (Italy) | Rifaximina |
| tr-TR | Turkish (Turkey) | Rifaksimin |
| ru-RU | Russian (Russian Federation) | Рифаксимин |
| nl-NL | Dutch (Netherlands) | rifaximin |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright